Management ChangeJun 9, 2026, 01:46 PM
GSK Director Hal Barron Appointed to Quantinuum Board
AI Summary
GSK plc announced that Dr. Hal Barron, a Non-Executive Director, has been appointed as an Independent Director and Chair of the Nominating and Corporate Governance Committee at Quantinuum Inc. This appointment took effect on June 4, 2026. The company made this disclosure in accordance with UK Listing Rule 6.4.9R(2).
Key Highlights
- Dr Hal Barron appointed Independent Director and Chair of the Nominating and Corporate Governance Committee of Quantinuum Inc. on June 4, 2026.
Price Impact
More from GSK